BE898967A - Medicament contenant de la muzolimine et son procede de preparation - Google Patents

Medicament contenant de la muzolimine et son procede de preparation

Info

Publication number
BE898967A
BE898967A BE0/212425A BE212425A BE898967A BE 898967 A BE898967 A BE 898967A BE 0/212425 A BE0/212425 A BE 0/212425A BE 212425 A BE212425 A BE 212425A BE 898967 A BE898967 A BE 898967A
Authority
BE
Belgium
Prior art keywords
muzolimine
weight
parts
preparing
same
Prior art date
Application number
BE0/212425A
Other languages
English (en)
Original Assignee
Bayer Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag filed Critical Bayer Ag
Publication of BE898967A publication Critical patent/BE898967A/fr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

L'invention concerne un médicament nouveau à base de muzolimine, contenant (a) 100 parties en poids de muzolimine, (b) 40 à 500 parties en poids d'amidon, (c) 20 à 100 parties en poids de cellulose , (d) 0,2 à 5 parties en poids de silice ainsi que (e) 0,1 à 3 parties en poids d'acide stéarique, de stéarate de calcium, de stéarate de magnésium et/ou de talc. Le médicament conforme à l'invention peut etre utilisé comme diurétique, salidiurétique, antithrombotique et antihypertensif.
BE0/212425A 1983-02-24 1984-02-21 Medicament contenant de la muzolimine et son procede de preparation BE898967A (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE19833306366 DE3306366A1 (de) 1983-02-24 1983-02-24 Muzolimin enthaltende arzneimittel, deren verwendung und verfahren zu deren herstellung

Publications (1)

Publication Number Publication Date
BE898967A true BE898967A (fr) 1984-08-21

Family

ID=6191654

Family Applications (1)

Application Number Title Priority Date Filing Date
BE0/212425A BE898967A (fr) 1983-02-24 1984-02-21 Medicament contenant de la muzolimine et son procede de preparation

Country Status (10)

Country Link
US (1) US4536511A (fr)
JP (1) JPS59157015A (fr)
BE (1) BE898967A (fr)
CH (1) CH662729A5 (fr)
DE (1) DE3306366A1 (fr)
ES (1) ES8503511A1 (fr)
FR (1) FR2541576B1 (fr)
GB (1) GB2135191B (fr)
IT (1) IT1173751B (fr)
ZA (1) ZA841331B (fr)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0701434B1 (fr) * 1993-06-04 2002-08-07 Warner-Lambert Company Preparations contenant de la silice en ameliorant le gout
US6395303B1 (en) * 1996-06-10 2002-05-28 Edward Mendell Co., Inc. Process for preparing a directly compressible solid dosage form containing microcrystalline cellulose
US6936277B2 (en) * 1995-01-09 2005-08-30 J. Rettenmaier & Soehne Gmbh & Co. Kg Pharmaceutical excipient having improved compressibility
US5948438A (en) * 1995-01-09 1999-09-07 Edward Mendell Co., Inc. Pharmaceutical formulations having improved disintegration and/or absorptivity
US6471994B1 (en) 1995-01-09 2002-10-29 Edward Mendell Co., Inc. Pharmaceutical excipient having improved compressibility
US5585115A (en) * 1995-01-09 1996-12-17 Edward H. Mendell Co., Inc. Pharmaceutical excipient having improved compressability

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH536632A (de) * 1968-10-21 1973-05-15 Boehringer Sohn Ingelheim Trägermasse für Arzneimitteltabletten und Verfahren zu deren Herstellung
AR207444A1 (es) * 1973-04-17 1976-10-08 Bayer Ag Procedimiento para la produccion de nuevas pirazolonas-(5)1-substituidas
DE2319280A1 (de) * 1973-04-17 1974-11-07 Bayer Ag 1-substituierte pyrazolone-(5), verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel
JPS5524136A (en) * 1978-08-11 1980-02-21 Asahi Chem Ind Co Ltd Medicinal composition

Also Published As

Publication number Publication date
JPS59157015A (ja) 1984-09-06
GB8404428D0 (en) 1984-03-28
GB2135191A (en) 1984-08-30
IT8419657A0 (it) 1984-02-16
ES529819A0 (es) 1985-03-16
DE3306366A1 (de) 1984-08-30
US4536511A (en) 1985-08-20
FR2541576B1 (fr) 1986-09-26
IT1173751B (it) 1987-06-24
ES8503511A1 (es) 1985-03-16
GB2135191B (en) 1986-07-09
FR2541576A1 (fr) 1984-08-31
CH662729A5 (de) 1987-10-30
IT8419657A1 (it) 1985-08-16
ZA841331B (en) 1984-10-31

Similar Documents

Publication Publication Date Title
US3432489A (en) Disaccharide polysulfate aluminium compound and method
BE881014A (fr) Procede de preparation d'organopolysiloxanes, et produits ainsi obtenus
IL112585A (en) N-terminally chemically modified G-CSF and analogs process for their preparation and pharmaceutical compositions containing them
SE8300981D0 (sv) Kostfiberprodukt
ES2055689T3 (es) Tableta para la segregacion mantenida de teofilina.
PT77898B (en) Process for the preparation of substituted 4-amino-methylenochromanes and 4-aminomethylenecromenes acting on the blood circulation and application thereof in the preparation of pharmaceutical compositions acting on the blood circulation
FR2375187A1 (fr) Cyclopentane-1-amines, procede pour leur preparation et produits contenant ces composes
FR2428042A1 (fr) Procede de preparation d'analogues de cephalosporine et nouveaux produits ainsi obtenus, a activite antimicrobienne
EP0144235A3 (fr) N6-(1-et 2-benzocycloalkyl)adénosines, compositions pharmaceutiques les contenant et leur procédés de préparation
FR2598433B1 (fr) Procede de production d'interleukine-2 humaine, interleukine-2 ainsi obtenue, son utilisation a titre de medicament et composition pharmaceutique la contenant
BE898967A (fr) Medicament contenant de la muzolimine et son procede de preparation
EP0249248A3 (fr) Dérivés de purine
FR2364228A1 (fr) Procede de preparation d'un catalyseur de trichlorure de titane utilisa
FR2496461B1 (fr) Procede de preparation de comprimes analgesiques, directement compressibles, d'acetaminophene renfermant de la carboxymethylcellulose sodique et nouveaux produits ainsi obtenus
CA2185242C (fr) Comprime renfermant du diclofenac-na a liberation prolongee
FR2442239A1 (fr) Procede de preparation de 4,l-benzoxazepines et de leur analogue thia, nouveaux produits ainsi obtenus et leur utilisation pour le traitement de troubles mentaux
FR2375238A1 (fr) Procede de preparation de 7-amino substitue acetamidooxadethia-cephalosporines et nouveaux produits ainsi obtenus, a activite antibacterienne
FR2384775A1 (fr) Derives de la morphine, leur procede de preparation et leur application comme medicament
FR2359176A1 (fr) Matiere a base de terephtalate de polyethylene ainsi qu'un procede pour sa preparation
FR2362849A1 (fr) Nouvelles heterocyclo-omega-pentanorprostaglandines aryliques substituees en position 2 et medicament les contenant
SE8404334D0 (sv) 16-fluoro-16,17-didehydro-prostanoids and process for their preparation
IE820253L (en) Chewable tablet.
FR2390422A1 (fr) Nouveaux 1-acyl-2-hydroxy-1,3-diaminopropanes, leur procede d'obtention et leur application comme medicaments
BE867205A (fr) Procede de preparation d'acide n,n-dimethylamino-methane-diphosphonique et produit ainsi obtenu
GR3003638T3 (fr)

Legal Events

Date Code Title Description
RE Patent lapsed

Owner name: BAYER A.G.

Effective date: 19890228